Ustekinumab Combined with Upadacitinib Promotes Mucosal Healing in Patients with Active Crohn's Disease Who Failed Anti-TNF-α Therapy (ChiCTR) - Sep 16, 2026 - P=N/A | N=110 | Completed | Sponsor: Shanghai Tenth People's Hospital; Shanghai Tenth People's Hospital
New trial • Crohn's disease • Gastroenterology • Immunology • Inflammatory Bowel Disease
|